VITREON INTRAOCULAR FLUID (PERFLUOROPERHYDROPHENANTHRENE)

FDA Premarket Approval P910068 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for 1) manufacturing site change: the new site for manufacturing the bulk medical grade perfluoroperhydrophenanthrene (apf-215m) will be at fluoromed, l. P. (fmlp), round rock, texas 78664; 2) manufacturing change: apf-215m will be manufactured from perfluoroperhydrophenanthrene raw material instead of from phenanthrene raw material; and 3) apf-215m specification change regarding testing parameter for lower boiling components.

DeviceVITREON INTRAOCULAR FLUID (PERFLUOROPERHYDROPHENANTHRENE)
Generic NameFluid, Intraocular
ApplicantAIR PRODUCTS & CHEMICALS, INC.
Date Received1999-04-26
Decision Date2001-04-04
PMAP910068
SupplementS001
Product CodeLWL 
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address AIR PRODUCTS & CHEMICALS, INC. 7201 Hamilton Blvd. allentown, PA 18951-501

Supplemental Filings

Supplement NumberDateSupplement Type
P910068Original Filing
S001 1999-04-26 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.